| Biological Sciences | Lifetime | 362 | US 211 | 99.95 |
| Medical and Health Sciences | Lifetime | 782 | US 404 | 99.96 |
| Nutrition and Dietetics | Lifetime | 3 | US 1 | 99.98 |
| Biochemistry | Lifetime | 1 | US 1 | 99.94 |
| Clinical Pharmacology | Lifetime | 65 | US 32 | 99.72 |
| Immunology | Lifetime | 131 | US 77 | 99.74 |
| Immunology and Allergy | Lifetime | 664 | US 275 | 86.43 |
| Nutrition and Dietetics | 2021-2025 | 63 | US 8 | 98.17 |
| Immunology | 2021-2025 | 208 | US 65 | 95.37 |
| Biochemistry | 2021-2025 | 57 | US 11 | 90.98 |
| Fatty Acid Research and Health | Lifetime | 1 | US 1 | 99.97 |
| Immune Response and Inflammation | Lifetime | 4 | US 3 | 99.98 |
| Inflammatory mediators and NSAID effects | Lifetime | 2 | US 1 | 99.95 |
| Eicosanoids and Hypertension Pharmacology | Lifetime | 2 | US 1 | 99.97 |
| Peroxisome Proliferator-Activated Receptors | Lifetime | 17 | US 13 | 99.72 |
| Cholesterol and Lipid Metabolism | Lifetime | 16 | US 12 | 99.61 |
| S100 Proteins and Annexins | Lifetime | 23 | US 10 | 99.39 |
| Metabolomics and Mass Spectrometry Studies | Lifetime | 66 | US 35 | 99.34 |
| Advanced Glycation End Products research | Lifetime | 39 | US 16 | 99.17 |
| Immune cells in cancer | Lifetime | 119 | US 46 | 99.17 |
| Neutrophil, Myeloperoxidase and Oxidative Mechanisms | Lifetime | 70 | US 33 | 99.15 |
| interferon and immune responses | Lifetime | 141 | US 75 | 98.97 |
| Adipokines, Inflammation, and Metabolic Diseases | Lifetime | 256 | US 117 | 98.76 |
| Macrophage Migration Inhibitory Factor | Lifetime | 49 | US 26 | 97.45 |
| Cell Adhesion Molecules Research | Lifetime | 536 | US 263 | 98.35 |
| Lipid metabolism and biosynthesis | Lifetime | 185 | US 90 | 97.90 |
| Asthma and respiratory diseases | Lifetime | 747 | US 272 | 98.35 |
| Natural Products and Biological Research | Lifetime | 39 | US 7 | 96.76 |
| Phagocytosis and Immune Regulation | Lifetime | 152 | US 61 | 96.96 |
| Cancer, Lipids, and Metabolism | Lifetime | 894 | US 412 | 96.93 |
| Cytokine Signaling Pathways and Interactions | Lifetime | 663 | US 294 | 96.77 |
| Sphingolipid Metabolism and Signaling | Lifetime | 272 | US 113 | 95.68 |
| Seaweed-derived Bioactive Compounds | Lifetime | 986 | US 58 | 89.04 |
| Eicosanoids and Hypertension Pharmacology | 2021-2025 | 4 | US 3 | 98.40 |
| Immune Response and Inflammation | 2021-2025 | 16 | US 6 | 98.21 |
| Fatty Acid Research and Health | 2021-2025 | 12 | US 3 | 98.32 |
| S100 Proteins and Annexins | 2021-2025 | 16 | US 5 | 96.17 |
| Inflammatory mediators and NSAID effects | 2021-2025 | 40 | US 7 | 93.59 |
| Neutrophil, Myeloperoxidase and Oxidative Mechanisms | 2021-2025 | 448 | US 99 | 79.26 |
| Advanced Glycation End Products research | 2021-2025 | 349 | US 30 | 76.56 |
| Macrophage Migration Inhibitory Factor | 2021-2025 | 110 | US 22 | 71.48 |
